APA
Sanai F. M., Altraif I. H., Alswat K., AlZanbagi A., Babatin M. A., AlMousa A., Almutairi N. H., Aljawad M. S., Alghamdi A. S., Aljumah A. A., Alalwan A. M., Al-Hamoudi W. K., Assiri A. M., Dahlan Y., Alsahafi A., Alothmani H. S., AlSaleemi M. S., Mousa W. A., Albenmousa A., Awny A., Albiladi H., Abdo A. A. & AlGhamdi H. (20190916). Real life efficacy of ledipasvir/sofosbuvir in hepatitis C genotype 4-infected patients with advanced liver fibrosis and decompensated cirrhosis. : The Journal of infection.
Chicago
Sanai Faisal M, Altraif Ibrahim H, Alswat Khalid, AlZanbagi Adnan, Babatin Mohamed A, AlMousa Abdallah, Almutairi Nawaf H, Aljawad Mohammed S, Alghamdi Abdullah S, Aljumah Abdulrahman A, Alalwan Abduljaleel M, Al-Hamoudi Waleed K, Assiri Abdullah M, Dahlan Yaser, Alsahafi Ashwaq, Alothmani Hammad S, AlSaleemi Mohammed S, Mousa Waleed A, Albenmousa Ali, Awny Abdelrahman, Albiladi Haziz, Abdo Ayman A and AlGhamdi Hamdan. 20190916. Real life efficacy of ledipasvir/sofosbuvir in hepatitis C genotype 4-infected patients with advanced liver fibrosis and decompensated cirrhosis. : The Journal of infection.
Harvard
Sanai F. M., Altraif I. H., Alswat K., AlZanbagi A., Babatin M. A., AlMousa A., Almutairi N. H., Aljawad M. S., Alghamdi A. S., Aljumah A. A., Alalwan A. M., Al-Hamoudi W. K., Assiri A. M., Dahlan Y., Alsahafi A., Alothmani H. S., AlSaleemi M. S., Mousa W. A., Albenmousa A., Awny A., Albiladi H., Abdo A. A. and AlGhamdi H. (20190916). Real life efficacy of ledipasvir/sofosbuvir in hepatitis C genotype 4-infected patients with advanced liver fibrosis and decompensated cirrhosis. : The Journal of infection.
MLA
Sanai Faisal M, Altraif Ibrahim H, Alswat Khalid, AlZanbagi Adnan, Babatin Mohamed A, AlMousa Abdallah, Almutairi Nawaf H, Aljawad Mohammed S, Alghamdi Abdullah S, Aljumah Abdulrahman A, Alalwan Abduljaleel M, Al-Hamoudi Waleed K, Assiri Abdullah M, Dahlan Yaser, Alsahafi Ashwaq, Alothmani Hammad S, AlSaleemi Mohammed S, Mousa Waleed A, Albenmousa Ali, Awny Abdelrahman, Albiladi Haziz, Abdo Ayman A and AlGhamdi Hamdan. Real life efficacy of ledipasvir/sofosbuvir in hepatitis C genotype 4-infected patients with advanced liver fibrosis and decompensated cirrhosis. : The Journal of infection. 20190916.